Profile
Evan A. Thackaberry currently works at Vigil Neuroscience, Inc., as Senior Vice President & Head-Early Development from 2020.
Dr. Thackaberry also formerly worked at Ra Pharmaceuticals, Inc., as Vice President-Non Clinical Development from 2017 to 2020.
Dr. Thackaberry received his doctorate degree from the University of Wisconsin.
Evan Thackaberry active positions
| Companies | Position | Start |
|---|---|---|
| VIGIL NEUROSCIENCE, INC. | Corporate Officer/Principal | 01/09/2020 |
Former positions of Evan Thackaberry
| Companies | Position | End |
|---|---|---|
| RA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2020 |
Training of Evan Thackaberry
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Ra Pharmaceuticals, Inc.
Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of glomerulonephritis, kidney disease and cardiovascular disease | Health Technology |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vigil Neuroscience, Inc.
Vigil Neuroscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics for neurodegenerative diseases | Health Technology |
- Stock Market
- Insiders
- Evan Thackaberry
















